Haemostatic and metabolic abnormalities in women with unexplained recurrent abortion

被引:63
作者
Coumans, ABC
Huijgens, PC
Jakobs, C
Schats, R
de Vries, JIP
van Pampus, MG
Dekker, GA [1 ]
机构
[1] Free Univ Amsterdam Hosp, Dept Obstet & Gynecol, Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, NL-1105 AZ Amsterdam, Netherlands
关键词
anticardiolipin antibodies; hyperhomocysteinaemia; protein C and S deficiency; recurrent abortion;
D O I
10.1093/humrep/14.1.211
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The objective of this study was to establish whether or not patients with unexplained recurrent abortion have an increased incidence of haemostatic or metabolic abnormalities. Fifty-two patients with a history of unexplained habitual abortion (two or more spontaneous abortions before 16 weeks' gestation) were tested for protein S, protein C and antithrombin (AT) III deficiency, activated protein C (aPC) resistance, hyperhomocysteinaemia and anticardiolipin antibodies (ACA), The control group consisted of 67 healthy women with a history of only uncomplicated pregnancies. Blood samples were taken for measuring protein S, protein C, AT III, ACA and activated protein C resistance and a methionine loading test was performed. Of the 46 patients tested for protein S deficiency, 8 (17.4%) were positive. Of the 43 patients tested, two (4.7%) were protein C deficient and none was AT In deficient, Of the 42 patients tested for ACA, eight (19.1%) had detectable antibodies, Of the 44 patients tested for aPC resistance, two (4.6%) were positive. Finally, 35 patients were tested for hyperhomocysteinaemia and six (17.1%) were positive. It was concluded that parous women with a history of unexplained recurrent abortion have an increased incidence of hyperhomocysteinaemia and a trend of increased incidence of ACA can be found.
引用
收藏
页码:211 / 214
页数:4
相关论文
共 27 条
[1]  
Balasch J, 1997, HUM REPROD, V12, P1094
[2]  
Bergant AM, 1997, HUM REPROD, V12, P1106
[3]  
Coulam CB, 1997, AM J REPROD IMMUNOL, V38, P57
[4]   FAMILIAL THROMBOPHILIA DUE TO A PREVIOUSLY UNRECOGNIZED MECHANISM CHARACTERIZED BY POOR ANTICOAGULANT RESPONSE TO ACTIVATED PROTEIN-C - PREDICTION OF A COFACTOR TO ACTIVATED PROTEIN-C [J].
DAHLBACK, B ;
CARLSSON, M ;
SVENSSON, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (03) :1004-1008
[5]   UNDERLYING DISORDERS ASSOCIATED WITH SEVERE EARLY-ONSET PREECLAMPSIA [J].
DEKKER, GA ;
DEVRIES, JIP ;
DOELITZSCH, PM ;
HUIJGENS, PC ;
VONBLOMBERG, BME ;
JAKOBS, C ;
VANGEIJN, HP .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 173 (04) :1042-1048
[6]  
DELIMA FFC, 1993, GYNECOL OBSTET INVES, V36, P221
[7]  
deVries JIP, 1997, BRIT J OBSTET GYNAEC, V104, P1248
[8]   THE 2ND INTERNATIONAL ANTICARDIOLIPIN STANDARDIZATION WORKSHOP THE KINGSTON ANTIPHOSPHOLIPID ANTIBODY STUDY (KAPS) GROUP [J].
HARRIS, EN .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1990, 94 (04) :476-484
[9]   VENOUS THROMBOSIS DUE TO POOR ANTICOAGULANT RESPONSE TO ACTIVATED PROTEIN-C - LEIDEN THROMBOPHILIA STUDY [J].
KOSTER, T ;
ROSENDAAL, FR ;
DERONDE, H ;
BRIET, E ;
VANDENBROUCKE, JP ;
BERTINA, RM .
LANCET, 1993, 342 (8886-7) :1503-1506
[10]   ABSENCE OF THROMBOSIS IN SUBJECTS WITH HETEROZYGOUS PROTEIN-C DEFICIENCY [J].
MILETICH, J ;
SHERMAN, L ;
BROZE, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (16) :991-996